Drug intelligence / Profile preview

Vitacon Forte

Development stage: Unknown
Lead developer: Teva Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Vitacon Forte is a multivitamin and mineral combination supplement formulated to address nutritional deficiencies. It contains a blend of B-complex vitamins, vitamin C, water-miscible forms of fat-soluble vitamins (A, D, E, K), iron, zinc, and folic acid. Developed and supplied by Actavis Totowa, it is specifically indicated for individuals with malabsorptive conditions, such as cystic fibrosis, who have difficulty absorbing standard fat-soluble vitamins. The product is administered orally as a capsule and is intended for use under medical supervision to meet the increased nutritional demands or compensate for impaired absorption associated with chronic illness, alcoholism, or pregnancy.

Brand names: Vitacon Forte

Beyond the preview

Go deeper on Vitacon Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitacon Forte.

Explore the full profile